ライフサイエンスコーパス: stress echocardiography

1 ctrocardiography, nuclear stress testing, or stress echocardiography).

2 ting, symptom questionnaires, and dobutamine stress echocardiography.

3 s incremental prognostic utility of exercise stress echocardiography.

4 s underwent exercise treadmill or dobutamine stress echocardiography.

5 improve the accuracy and reproducibility of stress echocardiography.

6 ication and prognosis in patients undergoing stress echocardiography.

7 ot have inducible ischemia, as determined by stress echocardiography.

8 ocardial perfusion defects during dobutamine stress echocardiography.

9 promising important addition to conventional stress echocardiography.

10 in 114 of the 117 patients during dobutamine stress echocardiography.

11 rophy on the accuracy of dobutamine-atropine stress echocardiography.

12 ial ischemia in patients not well suited for stress echocardiography.

13 le, well-tolerated alternative to dobutamine stress echocardiography.

14 entional visual interpretation of dobutamine stress echocardiography.

15 pic incompetence among patients referred for stress echocardiography.

16 tress testing and transesophageal dobutamine stress echocardiography.

17 154 patients without ischemia on dobutamine stress echocardiography.

18 a large patient group undergoing dobutamine stress echocardiography.

19 aging, stress single-photon emission CT, and stress echocardiography.

20 ed performance characteristics compared with stress echocardiography.

21 metric protocol in 119 patients referred for stress echocardiography.

22 were discharged and referred for outpatient stress echocardiography.

23 gradient increased or did not change during stress echocardiography.

24 5%) were prospectively submitted to exercise stress echocardiography.

25 sound contrast agents in patients undergoing stress echocardiography.

26 exercise capacity, and inducible ischemia on stress echocardiography.

27 d contrast agents; 18,749 of these underwent stress echocardiography.

28 ies, conducted an appropriateness review for stress echocardiography.

29 ely used in the prognostic interpretation of stress echocardiography.

30 ignificantly shorter than that of dobutamine stress echocardiography (15.1+/-3.9 min) (p = 0.0001).

31 (112 of 122 [92%]) than exercise testing and stress echocardiography (21 of 122 [17%]) or echocardiog

32 s (59 +/- 13 years old; 51% male) undergoing stress echocardiography (34% with treadmill exercise and

33 Fifty-four patients who underwent stress echocardiography (36 exercise, 18 dobutamine) and

34 rfusion (1,994 patients) and 5 on dobutamine stress echocardiography (446 patients).

35 PS, there was lower associated spending with stress echocardiography (-$4981 [-$4991 to -$4969]; P <

36 .55] vs. 55% [95% CI: 0.44 to 0.65]) but not stress echocardiography (53% [95% CI: 0.45 to 0.61] vs.

37 icular ejection fraction undergoing exercise stress echocardiography, a lower % of age-sex-predicted

38 ction underwent serial quantitative exercise stress echocardiography after 3 weeks on each treatment

39 artery disease (CAD) as measured by exercise stress echocardiography among outpatients with stable CA

40 Cardiologist-performed stress echocardiography and cardiac catheterization and

41 panel of noninvasive assessments, including stress echocardiography and cardiopulmonary exercise tes

42 secutive patients undergoing both dobutamine stress echocardiography and coronary angiography, electr

43 nts underwent multistage dobutamine-atropine stress echocardiography and diagnostic angiography.

44 Dobutamine-atropine stress echocardiography and DMIBI were comparable tests

45 Dobutamine-atropine stress echocardiography and DMIBI were moderately concor

46 Dobutamine-atropine stress echocardiography and DMIBI were similarly sensiti

47 rformed during low- and high-dose dobutamine stress echocardiography and have been applied to exercis

48 relation between myocardial ischemia during stress echocardiography and major events in patients wit

49 authors discuss the relative merits of both stress echocardiography and myocardial single photon emi

50 Patients underwent stress echocardiography and radionuclide perfusion imagi

51 (including exercise electrocardiography and stress echocardiography and single-photon emission compu

52 Dobutamine-atropine stress echocardiography and stress-rest DMIBI were perfo

53 perfusion abnormalities in real-time during stress echocardiography and will further add to the qual

54 , discusses new data regarding the safety of stress echocardiography, and highlights emerging roles f

55 h RTMCE improves the detection of CAD during stress echocardiography, and identifies those more likel

56 ing the critically ill), patients undergoing stress echocardiography, and patients with pulmonary hyp

57 photon emission computed tomography (SPECT), stress echocardiography, and positron emission tomograph

58 ocardiography, to contrast echocardiography, stress echocardiography, and TEE, among others.

59 Transthoracic echocardiography, stress echocardiography, and/or myocardial perfusion ima

60 g its diagnostic accuracy.3) Pharmacological stress echocardiography appears to provide superior spec

61 Comparable data for stress echocardiography are emerging.

62 n risk stratification of patients undergoing stress echocardiography are limited.

63 adionuclide myocardial perfusion imaging and stress echocardiography are noninvasive imaging techniqu

64 a in diabetic patients to define the role of stress echocardiography as a prognostic tool.

65 sought to document the safety of dobutamine stress echocardiography as it has evolved at a single ce

66 in a double-blind fashion during dobutamine stress echocardiography, at separate visits and in a ran

67 ess SPECT MPI and 298 patients who underwent stress echocardiography before publication of these crit

68 al radionucleotide stress test or dobutamine stress echocardiography before transplant.

69 s with class III/IV CHF underwent dobutamine stress echocardiography before treatment with bucindolol

70 Transesophageal atrial pacing stress echocardiography began at a heart rate of 10 beat

71 onary artery disease) who underwent exercise stress echocardiography between 2001 and 2012.

72 performed in 117 patients during dobutamine stress echocardiography by using an intravenous bolus of

73 ment of myocardial perfusion during exercise stress echocardiography can be achieved with imaging at

74 ntage of a prolonged dobutamine stage during stress echocardiography can be effectively combined with

75 We conclude that dobutamine stress echocardiography can be used to predict which pat

76 urrence of stress imaging (stress nuclear or stress echocardiography), coronary angiography, or coron

77 een appropriateness and publication year for stress echocardiography, CTA, or single-photon emission

78 Dobutamine-atropine stress echocardiography (DASE) (baseline, low dose [5 an

79 Dobutamine-atropine stress echocardiography (DASE) accurately detects scar,

80 We sought to compare dobutamine-atropine stress echocardiography (DASE) and dipyridamole Techneti

81 rdiographic Cardiac Risk Evaluation Applying Stress Echocardiography), DECREASE-IV, and POISE-1 (Peri

82 es (exercise ECG, stress nuclear methods, or stress echocardiography) did not improve clinical outcom

83 he diagnostic and prognostic capabilities of stress echocardiography, discusses new data regarding th

84 Stress echocardiography done using various methods has b

85 ablished diagnostic modalities of dobutamine stress echocardiography (DSE) and rest-redistribution th

86 od pressure (BP) responses during dobutamine stress echocardiography (DSE) are associated with abnorm

87 tion techniques were studied with dobutamine stress echocardiography (DSE) before TMLR.

88 valuated the incremental value of dobutamine stress echocardiography (DSE) for assessment of cardiac

89 safety and diagnostic accuracy of dobutamine stress echocardiography (DSE) for evaluating posttranspl

90 ject was to assess the utility of dobutamine stress echocardiography (DSE) for evaluation of women wi

91 determine the prognostic value of dobutamine stress echocardiography (DSE) for predicting long-term o

92 (WMA) during submaximal and peak dobutamine stress echocardiography (DSE) for the diagnosis of coron

93 d subsequent deterioration during dobutamine stress echocardiography (DSE) has been increasingly used

94 MCR during dobutamine stress echocardiography (DSE) identifies viable myocardi

95 prognostic significance of serial dobutamine stress echocardiography (DSE) in new heart transplant re

96 ctive value (NPV) of preoperative dobutamine stress echocardiography (DSE) in patients who fail to ac

97 ought to determine the utility of dobutamine stress echocardiography (DSE) in predicting cardiac even

98 To assess the role of dobutamine stress echocardiography (DSE) in these patients, DSE was

99 that the abnormalities induced by dobutamine stress echocardiography (DSE) may be of prognostic value

100 ial perfusion scintigraphy (MPS), dobutamine stress echocardiography (DSE) or coronary angiography, p

101 (TAPSE) protocol with a standard dobutamine stress echocardiography (DSE) protocol.

102 Because dobutamine stress echocardiography (DSE) provides assessment of lef

103 ron emission tomography (PET) and dobutamine stress echocardiography (DSE) were performed to quantita

104 tients who underwent conventional dobutamine stress echocardiography (DSE) without contrast.

105 in myocardial contraction during dobutamine stress echocardiography (DSE), particularly a biphasic r

106 to provide superior specificity to exercise stress echocardiography due to difficulties in test exec

107 C) published for radionuclide imaging (RNI), stress echocardiography (Echo), calcium scoring, coronar

108 Canine studies have shown that dobutamine stress echocardiography end points will occur at a lower

109 For U.K. women, the optimal strategy was stress echocardiography followed by catheter-based coron

110 RTCE) improves the sensitivity of dobutamine stress echocardiography for detecting coronary artery di

111 agnostic tests.2) Strong comparative data on stress echocardiography for detecting coronary artery di

112 etics and 11 305 nondiabetics) who underwent stress echocardiography for evaluation of known (n=5671)

113 Of 6174 consecutive adults undergoing stress echocardiography for evaluation of known or suspe

114 underwent outpatient exercise or dobutamine stress echocardiography for known or suspected coronary

115 Use of stress echocardiography for risk assessment in patients

116 he review assessed the risks and benefits of stress echocardiography for several indications or clini

117 ificity, and accuracy of dobutamine-atropine stress echocardiography for the detection of coronary ar

118 ockade affects the sensitivity of dobutamine stress echocardiography for the diagnosis of coronary ar

119 A microparticle rise during stress echocardiography had occurred only in those with

120 Stress cardiac MR imaging and stress echocardiography had similar specificity, accurac

121 Transesophageal atrial pacing stress echocardiography has been proposed as an efficien

122 Stress echocardiography has been shown to identify diffe

123 Dobutamine stress echocardiography has been the cornerstone of card

124 Increasingly, dobutamine stress echocardiography has been used for detection of c

125 Although dobutamine stress echocardiography has improved sensitivity and spe

126 Although appropriateness criteria for stress echocardiography have been developed to deliver h

127 mic myocardium, nuclear medicine studies and stress echocardiography have failed to adequately select

128 x (HR, 1.65; 95% CI, 1.41-1.93), ischemia at stress echocardiography (HR, 1.54; 95% CI, 1.32-1.80), a

129 R, 2.43; 95% CI, 1.83-3.22), and ischemia at stress echocardiography (HR, 1.71; 95% CI, 1.34-2.18).

130 Dobutamine stress echocardiography identified 60% of patients as lo

131 phology and function as assessed by rest and stress echocardiography in 156 asymptomatic National Foo

132 results strongly support the use of exercise stress echocardiography in asymptomatic aortic stenosis.

133 tudies emphasized the usefulness of exercise stress echocardiography in asymptomatic patients with ao

134 dly affects the negative predictive value of stress echocardiography in nondiabetic patients, whereas

135 overall diagnostic sensitivity of dobutamine stress echocardiography in our study cohort.

136 e performing exercise treadmill testing with stress echocardiography in outpatients with stable coron

137 as a potential substitute for pharmacologic stress echocardiography in patients admitted to the hosp

138 igations evaluating the prognostic effect of stress echocardiography in patients with stable coronary

139 ed supporting the prognostic capabilities of stress echocardiography in patients with various levels

140 To determine the value of dobutamine stress echocardiography in predicting cardiac events, in

141 e long-term prognostic utility of dobutamine stress echocardiography in predicting fatal and nonfatal

142 wall motion (WM) analysis during dobutamine stress echocardiography in predicting the outcome of pat

143 underwent both stress cardiac MR imaging and stress echocardiography in random order within 12 hours

144 s review discusses some of the advantages of stress echocardiography in relation to recent publicatio

145 diography, and highlights emerging roles for stress echocardiography in the areas of left ventricular

146 ral studies are available on the accuracy of stress echocardiography in the detection of coronary art

147 dly and shows good agreement with dobutamine stress echocardiography in the induction of myocardial i

148 atures, including ischemia during dobutamine stress echocardiography, in predicting postoperative car

149 r exercise, except among patients undergoing stress echocardiography, in whom the cutoff was < or =18

150 Use of stress echocardiography increased by 27.8% from 2005 (70

151 Transesophageal atrial pacing stress echocardiography is a feasible, well-tolerated al

152 Ischemia at stress echocardiography is a strong and independent pred

153 Dobutamine stress echocardiography is a useful tool for assessing l

154 Dobutamine stress echocardiography is a validated tool for the non-

155 Dobutamine-atropine stress echocardiography is an accurate test in most pati

156 Stress echocardiography is an established technique for

157 Ischemia during stress echocardiography is an independent predictor of d

158 Stress echocardiography is commonly employed for the cli

159 Real-time three-dimensional dobutamine stress echocardiography is feasible and sensitive in the

160 Stress echocardiography is increasingly used for the ass

161 ite these known pharmacodynamics, dobutamine stress echocardiography is routinely performed by advanc

162 Dobutamine stress echocardiography is widely accepted as a noninvas

163 In patients referred for stress echocardiography, LA size provides independent an

164 The versatility and advantage of stress echocardiography lie in the fact that it provides

165 Dobutamine-atropine stress echocardiography may be advantageous in patients

166 urement of GLS at rest and during dobutamine stress echocardiography may be helpful to enhance risk s

167 Studies are now suggesting that stress echocardiography may play novel roles in the eval

168 Stress GLS measured during dobutamine stress echocardiography may provide incremental prognost

169 Data suggest that dobutamine stress echocardiography may underestimate viability in c

170 The effect of the location of WMAs during stress echocardiography on prognostic outcome is unknown

171 ain (GLS) measured at rest and at dobutamine stress echocardiography on the outcome of patients with

172 aphy, and ventricular wall motion imaging by stress echocardiography or cardiac magnetic resonance.

173 cise electrocardiography, nuclear stress, or stress echocardiography) or anatomic testing.

174 cise electrocardiography, nuclear stress, or stress echocardiography) or coronary computed tomography

175 with resting or stress electrocardiography, stress echocardiography, or myocardial perfusion imaging

176 with resting or stress electrocardiography, stress echocardiography, or stress myocardial perfusion

177 d from 860 patients who underwent dobutamine stress echocardiography over a 2-year period.

178 The global and segmental stress echocardiography parameters of stunning were atte

179 w studies continue to document the safety of stress echocardiography, particularly with regard to arr

180 c accuracy and feasibility of bedside pacing stress echocardiography (PASE) as a potential substitute

181 ractile reserve, as determined by dobutamine stress echocardiography, predicts improvement in LVEF.

182 asive imaging techniques, such as dobutamine stress echocardiography, radionuclide scintigraphy and c

183 There were no major exercise stress echocardiography-related complications.

184 Dobutamine stress echocardiography reliably detects multivessel ste

185 Stress echocardiography represents a dynamic, versatile,

186 Stress echocardiography represents a well validated tool

187 $501 to $514 for pharmacologic and exercise stress echocardiography, respectively; and $946 to $1132

188 To compare the capability by stress echocardiography results to predict overall morta

189 The real-world clinical value of stress echocardiography (SE) in these patients is unknow

190 sk of cardiac events in patients with normal stress echocardiography (SE) who attained maximal age-pr

191 left atrial (LA) size in patients undergoing stress echocardiography (SE).

192 icular (RV) wall motion abnormalities during stress echocardiography (SE).

193 ve results.4) Current evidence suggests that stress echocardiography should be the first-line diagnos

194 re established techniques such as dobutamine stress echocardiography, single photon emission computed

195 for myocardial perfusion scintigraphy (MPS), stress echocardiography (STE), or coronary computed tomo

196 veral noninvasive imaging techniques such as stress echocardiography, stress nuclear studies, compute

197 or angiography alone, or treadmill exercise, stress echocardiography, stress thallium or predetermine

198 new two-stage transesophageal atrial pacing stress echocardiography (TAPSE) protocol with a standard

199 The adjusted OR of stress echocardiography testing among patients treated b

200 Nuclear stress testing and stress echocardiography testing following revascularizat

201 For stress echocardiography, the cumulative incidence of tes

202 With transesophageal atrial pacing stress echocardiography, the recovery period was shorter

203 total, 314 individuals underwent dobutamine stress echocardiography to detect or exclude myocardial

204 eckle tracking at rest and during dobutamine stress echocardiography to document the extent of myocar

205 he authors systematically employed exercise (stress) echocardiography to define those patients withou

206 an LVEF <or=55% that were poorly suited for stress echocardiography underwent DCMR in which left ven

207 Stress echocardiography uniquely identifies these high-r

208 ied 788 patients with RTCE during dobutamine stress echocardiography using intravenous commercially a

209 Dobutamine stress echocardiography was abnormal in 10 of these 25 w

210 GLS <|10|% measured during dobutamine stress echocardiography was also independently associate

211 In these strategies, stress echocardiography was consistently more effective

212 Transesophageal atrial pacing stress echocardiography was feasible in 100 of 104 patie

213 A standard protocol of dobutamine stress echocardiography was first performed.

214 Abnormal stress echocardiography was identified in 57 patients (3

215 Aspirin use among patients undergoing stress echocardiography was independently associated wit

216 standard 3-min dobutamine dose stage during stress echocardiography was modified by extending the pe

217 Dobutamine stress echocardiography was normal in 54 of the 67 women

218 Ischemia at stress echocardiography was observed in 768 (27%) diabet

219 Dobutamine stress echocardiography was performed in 1,171 patients

220 Dobutamine stress echocardiography was performed in 165 patients fo

221 Multistage dobutamine-atropine stress echocardiography was performed in 232 patients (a

222 Bedside transthoracic stress echocardiography was performed in 54 consecutive

223 Stress echocardiography was performed to estimate myocar

224 Dobutamine-atropine stress echocardiography was safely used to detect residu

225 the original stenosis zone during dobutamine stress echocardiography was significantly lower when two

226 Transesophageal atrial pacing stress echocardiography was successful in 35 of the 36 p

227 Dobutamine stress echocardiography was used in 30 patients (mean [+

228 Exercise stress echocardiography was used to identify inducible i

229 Pacing stress echocardiography was well tolerated, and only 4%

230 D, stress testing (nuclear stress testing or stress echocardiography) was performed in 7.9% of new-on

231 he results of exercise treadmill testing and stress echocardiography were compared with those obtaine

232 bability referred for dobutamine or exercise stress echocardiography were prospectively randomized to

233 ent were given at rest and during dobutamine stress echocardiography when a single coronary artery st

234 n patients unable to exercise, pharmacologic stress echocardiography with dobutamine or vasodilators

235 Dobutamine stress echocardiography with semiquantitative segmental

236 ype 2 diabetes mellitus underwent dobutamine stress echocardiography with tissue Doppler imaging on 2

237 Dobutamine stress echocardiography with use of the wall-motion scor

238 This article reviews the recent advances in stress echocardiography, with particular attention to ar

239 Stress echocardiography yields prognostic information fo